150 related articles for article (PubMed ID: 33226119)
1. Molecular and histologic insights on early onset cardiomyopathy in Danon disease females.
Fernández L; Casamayor Polo L; Bravo García-Morato M; Enguita Valls AB; Ruiz-Bravo E; Muñoz-Cabello P; Ibáñez K; Rodríguez-Laguna L; Martín-Arenas R; Ortega M; Palomares-Bralo M; Del Pozo Á; García-Guereta L; García-Miñaúr S; Lapunzina P; Vallespín E
Clin Genet; 2021 Mar; 99(3):481-483. PubMed ID: 33226119
[No Abstract] [Full Text] [Related]
2. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.
Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J
Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667
[TBL] [Abstract][Full Text] [Related]
3. A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy.
Yu L; Wan K; Han Y; Chen Y
Eur Heart J; 2018 Sep; 39(34):3263-3264. PubMed ID: 29240871
[No Abstract] [Full Text] [Related]
4. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease.
Türkmen H; Uysal F; Bostan ÖM
Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912
[TBL] [Abstract][Full Text] [Related]
5. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
Zaki A; Zaidi A; Newman WG; Garratt CJ
J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
[TBL] [Abstract][Full Text] [Related]
6. Danon disease presenting with early onset of hypertrophic cardiomyopathy and peripheral pigmentary retinal dystrophy in a female with a
Meinert M; Englund E; Hedberg-Oldfors C; Oldfors A; Kornhall B; Lundin C; Wittström E
Ophthalmic Genet; 2019 Jun; 40(3):227-236. PubMed ID: 31264915
[No Abstract] [Full Text] [Related]
7. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report.
Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M
BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794
[TBL] [Abstract][Full Text] [Related]
8. Danon disease: clinical features, evaluation, and management.
D'souza RS; Levandowski C; Slavov D; Graw SL; Allen LA; Adler E; Mestroni L; Taylor MR
Circ Heart Fail; 2014 Sep; 7(5):843-9. PubMed ID: 25228319
[No Abstract] [Full Text] [Related]
9. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene.
Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S
Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725
[TBL] [Abstract][Full Text] [Related]
10. Danon disease. A novel mutation in the LAMP-2 gene and ophthalmic abnormality.
He J; Wang Y; Jiang T
Herz; 2014 Nov; 39(7):877-9. PubMed ID: 23955649
[No Abstract] [Full Text] [Related]
11. Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy.
Dougu N; Joho S; Shan L; Shida T; Matsuki A; Uese K; Hirono K; Ichida F; Tanaka K; Nishino I; Inoue H
Circ J; 2009 Feb; 73(2):376-80. PubMed ID: 19057086
[TBL] [Abstract][Full Text] [Related]
12. Morphologic and clinical aspects of Danon disease in a patient with a mutation c.137G > A in the LAMP-2 gene.
Fidzianska A; Madej-Pilarczyk A; Walczak E; Kuch M
Neuropediatrics; 2013 Oct; 44(5):276-80. PubMed ID: 23504560
[TBL] [Abstract][Full Text] [Related]
13. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.
Fanin M; Nascimbeni AC; Fulizio L; Spinazzi M; Melacini P; Angelini C
Am J Pathol; 2006 Apr; 168(4):1309-20. PubMed ID: 16565504
[TBL] [Abstract][Full Text] [Related]
14. Abundant electrical myotonia and left ventricular noncompaction: Unusual features of Danon disease due to a novel mutation in LAMP2 gene.
Codron P; Pautot V; Tassin A; Sternberg D; Letournel F; Richard P; Nadaj-Pakleza A
Rev Neurol (Paris); 2019 Mar; 175(3):201-203. PubMed ID: 30527948
[No Abstract] [Full Text] [Related]
15. Progression of Danon disease with medical imaging: two case reports.
Wang S; Wang Q; Zhai N; Wang X; Li Z; Gan L; Cui Y
J Int Med Res; 2021 Feb; 49(2):300060520986676. PubMed ID: 33530800
[TBL] [Abstract][Full Text] [Related]
16. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy.
Xu J; Wang L; Liu X; Dai Q
Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081
[TBL] [Abstract][Full Text] [Related]
17. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry.
López-Sainz Á; Salazar-Mendiguchía J; García-Álvarez A; Campuzano Larrea O; López-Garrido MÁ; García-Guereta L; Fuentes Cañamero ME; Climent Payá V; Peña-Peña ML; Zorio-Grima E; Jordá-Burgos P; Díez-López C; Brugada R; García-Pinilla JM; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):479-486. PubMed ID: 30108015
[TBL] [Abstract][Full Text] [Related]
18. Paediatric hypertrophic cardiomyopathy secondary to Danon disease.
Tang K; Wu J; Liu X; Wang S
Cardiol Young; 2024 Jan; 34(1):201-204. PubMed ID: 37990583
[TBL] [Abstract][Full Text] [Related]
19. [Pathological diagnosis of Danon disease by endomyocardial biopsy].
Li Q; Chen D; Shang JF; Lu JY; Kang JR; Lyu J
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1276-1281. PubMed ID: 33287513
[TBL] [Abstract][Full Text] [Related]
20. A new phenotype of severe dilated cardiomyopathy associated with a mutation in the LAMP2 gene previously known to cause hypertrophic cardiomyopathy in the context of Danon disease.
Gourzi P; Pantou MP; Gkouziouta A; Kaklamanis L; Tsiapras D; Zygouri C; Constantoulakis P; Adamopoulos S; Degiannis D
Eur J Med Genet; 2019 Jan; 62(1):77-80. PubMed ID: 29753918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
